Literature DB >> 3926071

Incidence of hyperkalaemia induced by indomethacin in a hospital population.

A Zimran, M Kramer, M Plaskin, C Hershko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3926071      PMCID： PMC1416244          DOI： 10.1136/bmj.291.6488.107

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

Review 1.  Renal syndromes associated with nonsteroidal antiinflammatory drugs.

Authors:  D M Clive; J S Stoff
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

2.  Indomethacin-induced inhibition of prostaglandin with hyperkalemia.

Authors:  V Beroniade; L Cornielle; B Haraoui
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

3.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.

Authors:  G Ciabattoni; G A Cinotti; A Pierucci; B M Simonetti; M Manzi; F Pugliese; P Barsotti; G Pecci; F Taggi; C Patrono
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

4.  Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.

Authors:  S Y Tan; R Shapiro; R Franco; H Stockard; P J Mulrow
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

5.  Hyperkalemia associated with indomethacin.

Authors:  R C Goldszer; E L Coodley; M J Rosner; W M Simons; A B Schwartz
Journal:  Arch Intern Med       Date:  1981-05
  5 in total
  9 in total

1.  Increase in plasma potassium concentration following indomethacin administration: absence of a role for membrane Na-K ATPase.

Authors:  A Padhani; K Turaihi; D Junglee; R K Menon; P Dandona
Journal:  Agents Actions       Date:  1987-10

2.  Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.

Authors:  B Cardario; A A McKinnon
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

Review 3.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

4.  Risk of hyperkalemia associated with selective COX-2 inhibitors.

Authors:  Hisham Aljadhey; Wanzhu Tu; Richard A Hansen; Susan Blalock; D Craig Brater; Michael D Murray
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11       Impact factor: 2.890

Review 5.  Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.

Authors:  Gary Noroian; David Clive
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 6.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

Review 7.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

8.  The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi Arabia.

Authors:  Hisham Aljadhey
Journal:  Saudi Pharm J       Date:  2011-08-23       Impact factor: 4.330

9.  Nonsteroidal anti-inflammatory drugs. Proposed guidelines for monitoring toxicity.

Authors:  T M Bush; T L Shlotzhauer; K Imai
Journal:  West J Med       Date:  1991-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.